跳至主要内容
临床试验/CTRI/2024/06/068682
CTRI/2024/06/068682招募中2 期

Pilot Study to assess the efficacy of cannabinoid-rich Oral cannabis extract for pain management in cancer patients undergoing cancer directed treatment (surgery, systemic therapy, radiation therapy)and who have received systemic analgesics

Whole leaf Organics Pvt Ltd1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年6月30日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Improvement in pain relief

研究概览

简要总结

Pilot Study to assess the efficacy of cannabinoid-rich Oral cannabis extract for pain management in cancer patients undergoing cancer directed treatment (surgery, systemic therapy, radiation therapy) and who have received systemic analgesics.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Adult patients Histopathologically confirmed cancer diagnosis Moderate or severe pain Stable regime of pain management inclusive of NSAIDS weak opioid opioids Palliative intent therapy.

排除标准

  • Major psychiatric disorder Cardiovascular disorder Epilepsy Significant renal or hepatic impairment Pregnancy Lactating Women Patients who were currently using or had used cannabinoid based medications within 30 days of study entry.

结局指标

主要结局

Improvement in pain relief

时间窗: 90 Days

Using baseline assessment measures gathered at visit 0

时间窗: 90 Days

Screening assessments collected at visits 1 to 5 and follow up

时间窗: 90 Days

will be used to determine whether the administration of

时间窗: 90 Days

cannabinoid rich oral cannabis extract will improve pain relief

时间窗: 90 Days

in individuals with chronic pain Assessments will be made

时间窗: 90 Days

using a visual analogue scale

时间窗: 90 Days

次要结局

  • Quality of life(Baseline 30 days 60 days 90 days)

研究者

发起方
Whole leaf Organics Pvt Ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Manish Singhal

Indraprastha Apollo Hospitals New Delhi

研究点 (1)

Loading locations...

相似试验